NWBO · Northwest Biotherapeutics Inc · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“Because of recurring operating losses and operating cash flow deficits, there is substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date of this filing. The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, however, they do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities that may result from the outcome of this uncertainty.”View the 10-Q filed Aug 14, 2026
Every disclosed holder of NWBO in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns NWBO
13F quarter Jun 30, 2026| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 2,221,544 | 0.13% |
| Insiders (Forms 3, 4, 5) | 0 | 0.00% |
| 13D/G-only blocks | 0 | 0.00% |
| Remaining | 1,703,416,449 | 99.87% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 1,705,637,993, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of NWBO
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
COMPASS FINANCIAL MANAGEMENT LLC
13F
CIK 2148724 · Registered investment adviser · Jun 30, 2026
|
1,215,500 | ||
| 2 |
KELLEHER FINANCIAL ADVISORS
13F
CIK 1507971 · Registered investment adviser · Jun 30, 2026
|
800,000 | ||
| 3 |
VSM Wealth Advisory, LLC
13F
CIK 2050660 · Registered investment adviser · Jun 30, 2026
|
80,574 | ||
| 4 |
Opus Capital Group, LLC
13F
CIK 1330325 · Registered investment adviser · Jun 30, 2026
|
60,150 | ||
| 5 |
Ethos Financial Group, LLC
13F
CIK 1954242 · Unknown · Jun 30, 2026
|
39,070 | ||
| 6 |
Williams Jones Wealth Management, LLC.
13F
CIK 1788587 · Registered investment adviser · Jun 30, 2026
|
25,000 | ||
| 7 |
Coston, McIsaac & Partners
13F
CIK 1945037 · Unknown · Jun 30, 2026
|
1,000 | ||
| 8 |
HANTZ FINANCIAL SERVICES, INC.
13F
CIK 1071061 · Registered investment adviser · Jun 30, 2026
|
250 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.